IL-22 is induced by S100/calgranulin and impairs cholesterol efflux in macrophages by downregulating ABCG1

Journal of Lipid Research

Volumn 55, Issue 3, 2014, Pages 443-454

  Chellan, Bijoy ^a   Yan, Ling ^a   Sontag, Timothy J ^a   Reardon, Catherine A ^a   Hofmann Bowman, Marion A ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Cholesterol transporters; Interleukin 22; Peritoneal macrophages; Receptor for advanced glycation endproducts; S100A12

Indexed keywords

ABC TRANSPORTER G1; ADVANCED GLYCATION END PRODUCT RECEPTOR; CALGRANULIN A; CALGRANULIN B; CHOLESTEROL; INTERLEUKIN 22; LIPID; MESSENGER RNA; RECOMBINANT PROTEIN;

ANIMAL CELL; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; BONE MARROW CELL; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; FAT CONTENT; HOMEOSTASIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; T LYMPHOCYTE; TRANSGENIC MOUSE; WILD TYPE;

CHOLESTEROL TRANSPORTERS; INTERLEUKIN-22; PERITONEAL MACROPHAGES; RECEPTOR FOR ADVANCED GLYCATION ENDPRODUCTS; S100A12;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; BLOTTING, WESTERN; CALGRANULIN A; CALGRANULIN B; CELL LINE, TUMOR; CELLS, CULTURED; CHOLESTEROL; DOWN-REGULATION; HUMANS; INTERLEUKINS; MACROPHAGES; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTORS, IMMUNOLOGIC; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; S100 PROTEINS;

EID: 84894700972     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M044305     Document Type: Article

References (49)

1. Zenewicz, L. A., and R. A. Flavell. 2011. Recent advances in IL-22 biology. Int. Immunol. 23: 159-163.
2. Pan, H. F., X. P. Li, S. G. Zheng, and D. Q. Ye. 2013. Emerging role of interleukin-22 in autoimmune diseases. Cytokine Growth Factor Rev. 24: 51-57.
3. Kolls, J. K., P. B. McCray, and Y. R. Chan. 2008. Cytokine-mediated regulation of antimicrobial proteins. Nat. Rev. Immunol. 8: 829-835.
4. Wolk, K., E. Witte, E. Wallace, W. D. Döcke, S. Kunz, K. Asadullah, H. D. Volk, W. Sterry, and R. Sabat. 2006. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur. J. Immunol. 36: 1309-1323.
5. Boniface, K., E. Guignouard, N. Pedretti, M. Garcia, A. Delwail, F. X. Bernard, F. Nau, G. Guillet, G. Dagregorio, H. Yssel, et al. 2007. A role for T cell-derived interleukin 22 in psoriatic skin inflammation. Clin. Exp. Immunol. 150: 407-415. (Pubitemid 350098734)
6. Wolk, K., H. S. Haugen, W. Xu, E. Witte, K. Waggie, M. Anderson, E. Vom Baur, K. Witte, K. Warszawska, S. Philipp, et al. 2009. IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not. J. Mol. Med. (Berl.). 87: 523-536.
7. Geboes, L., L. Dumoutier, H. Kelchtermans, E. Schurgers, T. Mitera, J. C. Renauld, and P. Matthys. 2009. Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice. Arthritis Rheum. 60: 390-395.
8. Meephansan, J., K. Ruchusatsawat, W. Sindhupak, P. S. Thorner, and J. Wongpiyabovorn. 2011. Effect of methotrexate on serum levels of IL-22 in patients with psoriasis. Eur. J. Dermatol. 21: 501-504.
9. da Rocha, L. F., Jr., A. L. Duarte, A. T. Dantas, H. A. Mariz, R. Pitta Ida, S. L. Galdino, and M. G. Pitta. 2012. Increased serum interleukin 22 in patients with rheumatoid arthritis and correlation with disease activity. J. Rheumatol. 39: 1320-1325.
10. Friedewald, V. E., J. C. Cather, J. M. Gelfand, K. B. Gordon, G. H. Gibbons, S. M. Grundy, M. T. Jarratt, J. G. Krueger, P. M. Ridker, N. Stone, et al. 2008. AJC editor's consensus: psoriasis and coronary artery disease. Am. J. Cardiol. 102: 1631-1643.
11. Bobryshev, Y. V., V. R. Babaev, S. Iwasa, R. S. Lord, and T. Watanabe. 1999. Atherosclerotic lesions of apolipoprotein E deficient mice contain cells expressing S100 protein. Atherosclerosis. 143: 451-454. (Pubitemid 29166928)
12. Burke, A. P., F. D. Kolodgie, A. Zieske, D. R. Fowler, D. K. Weber, P. J. Varghese, A. Farb, and R. Virmani. 2004. Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study. Arterioscler. Thromb. Vasc. Biol. 24: 1266-1271. (Pubitemid 38880019)
13. Healy, A. M., M. D. Pickard, A. D. Pradhan, Y. Wang, Z. Chen, K. Croce, M. Sakuma, C. Shi, A. C. Zago, J. Garasic, et al. 2006. Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events. Circulation. 113: 2278-2284. (Pubitemid 43947973)
14. Morrow, D. A., Y. Wang, K. Croce, M. Sakuma, M. S. Sabatine, H. Gao, A. D. Pradhan, A. M. Healy, J. Buros, C. H. McCabe, et al. 2008. Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial. Am. Heart J. 155: 49-55. (Pubitemid 350234770)
15. Foell, D., D. Kane, B. Bresnihan, T. Vogl, W. Nacken, C. Sorg, O. Fitzgerald, and J. Roth. 2003. Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis. Rheumatology (Oxford). 42: 1383-1389. (Pubitemid 37407031)
16. Brinar, M., I. Cleynen, T. Coopmans, G. Van Assche, P. Rutgeerts, and S. Vermeire. 2010. Serum S100A12 as a new marker for inflammatory bowel disease and its relationship with disease activity. Gut. 59: 1728-1729.
17. Baillet, A., C. Trocmé, S. Berthier, M. Arlotto, L. Grange, J. Chenau, S. Quétant, M. Sève, F. Berger, R. Juvin, et al. 2010. Synovial fluid proteomic fingerprint: S100A8, S100A9 and S100A12 proteins discriminate rheumatoid arthritis from other inflammatory joint diseases. Rheumatology (Oxford). 49: 671-682.
18. Averill, M. M., C. Kerkhoff, and K. E. Bornfeldt. 2012. S100A8 and S100A9 in cardiovascular biology and disease. Arterioscler. Thromb. Vasc. Biol. 32: 223-229.
19. Hofmann, M. A., S. Drury, C. Fu, W. Qu, A. Taguchi, Y. Lu, C. Avila, N. Kambham, A. Bierhaus, P. Nawroth, et al. 1999. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell. 97: 889-901. (Pubitemid 29375048)
20. Xie, J., D. S. Burz, W. He, I. B. Bronstein, I. Lednev, and A. Shekhtman. 2007. Hexameric calgranulin C (S100A12) binds to the receptor for advanced glycated end products (RAGE) using symmetric hydrophobic target-binding patches. J. Biol. Chem. 282: 4218-4231. (Pubitemid 47084493)
21. Yan, L., P. Bjork, R. Butuc, J. Gawdzik, J. Earley, G. Kim, and M. A. Hofmann Bowman. 2013. Beneficial effects of quinoline-3-carboxamide (ABR-215757) on atherosclerotic plaque morphology in S100A12 transgenic ApoE null mice. Atherosclerosis. 228: 69-79.
22. Srikrishna, G., J. Nayak, B. Weigle, A. Temme, D. Foell, L. Hazelwood, A. Olsson, N. Volkmann, D. Hanein, and H. H. Freeze. 2010. Carboxylated N-glycans on RAGE promote S100A12 binding and signaling. J. Cell. Biochem. 110: 645-659.
23. Hofmann Bowman, M. A., J. Gawdzik, U. Bukhari, A. N. Husain, P. T. Toth, G. Kim, J. Earley, and E. M. McNally. 2011. S100A12 in vascular smooth muscle accelerates vascular calcification in apolipoprotein E-null mice by activating an osteogenic gene regulatory program. Arterioscler. Thromb. Vasc. Biol. 31: 337-344.
24. Tabas, I. 2002. Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. J. Clin. Invest. 110: 905-911.
25. Abela, G. S. 2010. Cholesterol crystals piercing the arterial plaque and intima trigger local and systemic inflammation. J. Clin. Lipidol. 4: 156-164.
26. Kennedy, M. A., G. C. Barrera, K. Nakamura, A. Baldán, P. Tarr, M. C. Fishbein, J. Frank, O. L. Francone, and P. A. Edwards. 2005. ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metab. 1: 121-131. (Pubitemid 43977167)
27. Jessup, W., I. C. Gelissen, K. Gaus, and L. Kritharides. 2006. Roles of ATP binding cassette transporters A1 and G1, scavenger receptor BI and membrane lipid domains in cholesterol export from macrophages. Curr. Opin. Lipidol. 17: 247-257. (Pubitemid 43786058)
28. Weischenfeldt, J., and B. Porse. 2008. Bone marrow-derived macrophages (BMM): isolation and applications. CSH Protoc. 2008: doi:10.1101/pdb.prot5080.
29. Schwende, H., E. Fitzke, P. Ambs, and P. Dieter. 1996. Differences in the state of differentiation of THP-1 cells induced by phorbol ester and 1,25-dihydroxyvitamin D3. J. Leukoc. Biol. 59: 555-561. (Pubitemid 26156616)
30. Liu, L., A. E. Bortnick, M. Nickel, P. Dhanasekaran, P. V. Subbaiah, S. Lund-Katz, G. H. Rothblat, and M. C. Phillips. 2003. Effects of apolipoprotein A-I on ATP-binding cassette transporter A1-mediated efflux of macrophage phospholipid and cholesterol: formation of nascent high density lipoprotein particles. J. Biol. Chem. 278: 42976-42984. (Pubitemid 37345910)
31. Yang, Z., T. Tao, M. J. Raftery, P. Youssef, N. Di Girolamo, and C. L. Geczy. 2001. Proinflammatory properties of the human S100 protein S100A12. J. Leukoc. Biol. 69: 986-994. (Pubitemid 32577902)
32. Kishimoto, K., S. Kaneko, K. Ohmori, T. Tamura, and K. Hasegawa. 2006. Olopatadine suppresses the migration of THP-1 monocytes induced by S100A12 protein. Mediators Inflamm. 2006: 42726.
33. Guttman-Yassky, E., M. A. Lowes, J. Fuentes-Duculan, L. C. Zaba, I. Cardinale, K. E. Nograles, A. Khatcherian, I. Novitskaya, J. A. Carucci, R. Bergman, et al. 2008. Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis. J. Immunol. 181: 7420-7427.
34. Hofmann Bowman, M., J. Wilk, A. Heydemann, G. Kim, J. Rehman, J. A. Lodato, J. Raman, and E. M. McNally. 2010. S100A12 mediates aortic wall remodeling and aortic aneurysm. Circ. Res. 106: 145-154.
35. Han, J., D. P. Hajjar, M. Febbraio, and A. C. Nicholson. 1997. Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36. J. Biol. Chem. 272: 21654-21659. (Pubitemid 27374044)
36. Costet, P., Y. Luo, N. Wang, and A. R. Tall. 2000. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J. Biol. Chem. 275: 28240-28245.
37. Cui, G., X. Qin, L. Wu, Y. Zhang, X. Sheng, Q. Yu, H. Sheng, B. Xi, J. Z. Zhang, and Y. Q. Zang. 2011. Liver X receptor (LXR) mediates negative regulation of mouse and human Th17 differentiation. J. Clin. Invest. 121: 658-670.
38. Brown, M. S., J. L. Goldstein, M. Krieger, Y. K. Ho, and R. G. Anderson. 1979. Reversible accumulation of cholesteryl esters in macrophages incubated with acetylated lipoproteins. J. Cell Biol. 82: 597-613. (Pubitemid 10222832)
39. Ho, Y. K., M. S. Brown, and J. L. Goldstein. 1980. Hydrolysis and excretion of cytoplasmic cholesteryl esters by macrophages: stimulation by high density lipoprotein and other agents. J. Lipid Res. 21: 391-398.
40. Small, D. M., M. G. Bond, D. Waugh, M. Prack, and J. K. Sawyer. 1984. Physicochemical and histological changes in the arterial wall of nonhuman primates during progression and regression of atherosclerosis. J. Clin. Invest. 73: 1590-1605. (Pubitemid 14084475)
41. Rapp, J. H., W. E. Connor, D. S. Lin, T. Inahara, and J. M. Porter. 1983. Lipids of human atherosclerotic plaques and xanthomas: clues to the mechanism of plaque progression. J. Lipid Res. 24: 1329-1335. (Pubitemid 14245702)
42. Lundberg, B. 1985. Chemical composition and physical state of lipid deposits in atherosclerosis. Atherosclerosis. 56: 93-110. (Pubitemid 15049652)
43. Abela, G. S., and K. Aziz. 2005. Cholesterol crystals cause mechanical damage to biological membranes: a proposed mechanism of plaque rupture and erosion leading to arterial thrombosis. Clin. Cardiol. 28: 413-420. (Pubitemid 41254303)
44. Abela, G. S., K. Aziz, A. Vedre, D. R. Pathak, J. D. Talbott, and J. Dejong. 2009. Effect of cholesterol crystals on plaques and intima in arteries of patients with acute coronary and cerebrovascular syndromes. Am. J. Cardiol. 103: 959-968.
45. Foell, D., H. Wittkowski, C. Kessel, A. Luken, T. Weinhage, G. Varga, T. Vogl, T. Wirth, D. Viemann, P. Bjork, et al. 2013. Proinflammatory S100A12 can activate human monocytes via Toll-like receptor 4. Am. J. Respir. Crit. Care Med. 187: 1324-1334.
46. Yan, S. F., R. Ramasamy, and A. M. Schmidt. 2010. The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature. Circ. Res. 106: 842-853.
47. Chen, Y., E. M. Akirav, W. Chen, O. Henegariu, B. Moser, D. Desai, J. M. Shen, J. C. Webster, R. C. Andrews, A. M. Mjalli, et al. 2008. RAGE ligation affects T cell activation and controls T cell differentiation. J. Immunol. 181: 4272-4278.
48. Akirav, E. M., P. Preston-Hurlburt, J. Garyu, O. Henegariu, R. Clynes, A. M. Schmidt, and K. C. Herold. 2012. RAGE expression in human T cells: a link between environmental factors and adaptive immune responses. PLoS ONE. 7: e34698.
49. Mehta, N. N., R. Li, P. Krishnamoorthy, Y. Yu, W. Farver, A. Rodrigues, A. Raper, M. Wilcox, A. Baer, S. DerOhannesian, et al. 2012. Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis. Atherosclerosis. 224: 218-221.